articleThe Lancet OncologyJan 1, 2008Closed access

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

NWNR WilliamsJFJohn F ForbesJCJack CuzickABAman BuzdarAHAnthony Howell
PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

916
total citations
FWCI
46.78
Percentile
100%
References
21
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Anastrozole
  • Tamoxifen
  • Medicine
  • Breast cancer
  • Hazard ratio
  • Internal medicine
  • Oncology
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.